Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Injections 54 Cisplatin 49 Paclitaxel 48 Carboplatin 43 Gemcitabine 38 pembrolizumab 36 Docetaxel 36 Capecitabine 36 Drug Therapy 34 anlotinib 25 Bevacizumab 25 Fluorouracil 24 Cyclophosphamide 24 icotinib 23 Oxaliplatin 20 fludarabine 19 Pemetrexed 17 Leucovorin 16 Irinotecan 16 Temozolomide 14 Nivolumab 14 Doxorubicin 14 Cetuximab 14 camrelizumab 13 apatinib 13 Trastuzumab 12 Rituximab 11 Fulvestrant 11 Etoposide 11 tesetaxel 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × INDUSTRY × BAY 86-7548 × Clear all

NCT03731026 2018-11-06

The LightPath® and 68Ga-RM2 in Breast Cancer Study

Lightpoint Medical Limited

Phase 3 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡